Katarzyna Korzeniowska

Katarzyna Korzeniowska

Auto-generated profile, based on publicly available information

Katarzyna Korzeniowska

Department of Clinical Pharmacology, Poznan University of Medical Sciences, 61-861 Poznan, Poland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
ACArtur Cieslewicz
Artur Cieslewicz
MDMagdalena Dudek
Magdalena Dudek
IKIwona Krela-Kaźmierczak
Iwona Krela-Kaźmierczak
AJAnna Jabłecka
Anna Jabłecka
MLMaciej Lesiak
Maciej Lesiak
KKKatarzyna Korzeniowska
Katarzyna Korzeniowska
The COVID-19 pandemic has caused more than 3 million deaths worldwide. Recently developed genetically engineered vaccines are the most critical solution for controlling the pandemic. Clinical trials on a large number of participants confirmed their safety and efficacy. However, with the growing number of vaccinated people, new infrequent adverse effects have been reported, not described in the medicinal product characteristics. We would like to report a case of acute pancreatic injury that occurred shortly after administering Pfizer BioNTech COVID-19 mRNA vaccine (Comirnaty). The report points out the potential need for close monitoring of patients reporting abdominal pain after vaccination (unresponsive to standard oral painkillers) because such symptom can be associated with acute pancreatitis.